Vasculoprotective Effects of Combined Endothelial Progenitor Cells and Mesenchymal Stem Cells in Diabetic Wound Care: Their Potential Role in Decreasing Wound-Oxidative Stress

Figure 1

The percentages of wound closure in the control group with implanted fibrin gel (control), diabetic wound group with implanted fibrin gel (DM), diabetic wound group with implanted fibrin gel and MSCs (DM + MSCs), diabetic wound group with implanted fibrin gel and EPCs (DM + EPCs), and diabetic wound group with implanted fibrin gel and combined MSCs and EPCs (DM + MSCs + EPCs) on day 7 and day 14 are shown. The data are presented as the means ± SEM. ^∗∗𝑃<0.005: significant difference compared to the control group. ^##𝑃<0.005: significant difference compared to the DM group. ^†𝑃<0.05: significant difference compared to the DM + MSCs + EPCs group. ^§𝑃<0.05: significant difference compared to the DM + MSCs group.